Q1 2018 Holdings
Filed 2018-05-15 | 118 holdings | $254.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $48.1M | 2,745,705 | 18.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $35.1M | 7,366,460 | 13.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $31.6M | 482,467 | 12.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.9M | 366,000 | 11.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $29.0M | 741,016 | 11.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $25.7M | 319,920 | 10.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $21.4M | 753,322 | 8.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.4M | 146,000 | 6.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.1M | 2,602,733 | 5.2% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $124.8K | 8,621,383 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $104.9K | 2,548,111 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $97.7K | 5,227,035 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $93.9K | 6,609,894 | 0.0% |
| Avexis Inc | COM | 05366U100 | $93.4K | 755,798 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $91.1K | $99,100,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $82.7K | 794,338 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $66.9K | 2,900,000 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $62.8K | 588,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $57.3K | $75,000,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $52.2K | 1,068,680 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $50.7K | 1,643,031 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $48.1K | 649,000 | 0.0% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $45.3K | $45,700,000 | 0.0% |
| Lannet Inc | COM | 516012101 | $44.0K | 2,741,077 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $42.0K | 191,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $41.6K | 1,384,470 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $38.6K | $48,000,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $38.4K | 1,158,841 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $35.8K | $31,500,000 | 0.0% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $35.3K | 566,800 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $34.9K | $40,500,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $34.8K | 378,950 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $34.2K | 550,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $32.7K | 832,500 | 0.0% |
| Davita Inc(DVA) | COM | 23918K108 | $32.1K | 486,427 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $32.1K | 1,858,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $31.6K | 810,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $31.3K | $27,600,000 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $31.0K | 262,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $29.5K | 3,180,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $28.6K | $36,000,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $27.9K | 165,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $27.6K | 3,788,540 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $27.5K | 697,194 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $26.5K | 882,462 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $26.3K | 484,055 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $25.4K | 225,452 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.1K | 2,500,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $24.0K | 615,000 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $23.9K | 2,627,540 | 0.0% |